Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Byerly

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Child and Adolescent Psychopharmacology|October 27, 2010
A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetinePaul A Nakonezny, Carroll W Hughes, Taryn L Mayes, et al.
Molecular Autism|August 4, 2017
Erratum to: Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndromeLauren E Ethridge, Stormi P White, Matthew W Mosconi, et al.
Molecular Autism|June 10, 2017
Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndromeLauren E Ethridge, Stormi P White, Matthew W Mosconi, et al.
Journal of Psychiatric Research|April 14, 2015
Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorderPaul A Nakonezny, David W Morris, Tracy L Greer, et al.
Journal of Neurodevelopmental Disorders|March 21, 2017
A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndromeJun Wang, Lauren E Ethridge, Matthew W Mosconi, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2016
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of SchizophreniaRobert A Rosenheck, Douglas L Leslie, Kyaw J Sint, et al.
Schizophrenia Research|February 26, 2013
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trialT Scott Stroup, Matthew J Byerly, Henry A Nasrallah, et al.
Schizophrenia Bulletin|August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentT Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Child and Adolescent Psychopharmacology|October 27, 2010
A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetinePaul A Nakonezny, Carroll W Hughes, Taryn L Mayes, et al.
Molecular Autism|August 4, 2017
Erratum to: Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndromeLauren E Ethridge, Stormi P White, Matthew W Mosconi, et al.
Molecular Autism|June 10, 2017
Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndromeLauren E Ethridge, Stormi P White, Matthew W Mosconi, et al.
Journal of Psychiatric Research|April 14, 2015
Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorderPaul A Nakonezny, David W Morris, Tracy L Greer, et al.
Journal of Neurodevelopmental Disorders|March 21, 2017
A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndromeJun Wang, Lauren E Ethridge, Matthew W Mosconi, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2016
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of SchizophreniaRobert A Rosenheck, Douglas L Leslie, Kyaw J Sint, et al.
Schizophrenia Research|February 26, 2013
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trialT Scott Stroup, Matthew J Byerly, Henry A Nasrallah, et al.
Schizophrenia Bulletin|August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentT Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Pageof 3